Pharmacologic Restraint Used in 3 Percent of Pediatric Mental Health Admissions
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 11, 2023 -- The use of pharmacologic restraints occurs in 3 percent of hospitalizations for children admitted with a primary mental health diagnosis, according to a study published online Dec. 11 in Pediatrics.
Benjamin Masserano, M.D., from the University of Texas Southwestern in Dallas, and colleagues conducted a retrospective, cross-sectional study using the Pediatric Health Information System database, including children aged 5 to 17 years with a primary mental health diagnosis between 2016 and 2021. The rates of pharmacologic restraint use per 1,000 patient days in medical inpatient units were examined for 13 mental health diagnoses.
The researchers found that 3 percent of admissions and 1.3 percent of patient days of the 91,898 hospitalizations across 43 hospitals involved pharmacologic restraint. The incidence of pharmacologic restraint use increased by 141 percent, while trends in the rate of use remained stable. Diagnoses with the highest rates of pharmacologic restraint days included autism, substance-related disorders, and disruptive disorders (79.4, 45.0, and 44.8 per 1,000 patient-days, respectively). A significant increase in restraint rate was seen in disruptive disorders, bipolar disorders, eating disorders, and somatic disorders (rate ratios [95 percent confidence intervals], 1.4 [1.1 to 1.6], 2.0 [1.4 to 3.0], 2.4 [1.5 to 3.9], and 4.2 [1.9 to 9.1], respectively). Significant decreases in the rate were seen for autism and anxiety disorders (rate ratios [95 percent confidence intervals], 0.8 [0.6 to 1.0] and 0.3 [0.2 to 0.6], respectively).
"These findings can assist practitioners in identifying at-risk patients, guiding targeted interventions, and developing quality improvement initiatives aimed at identifying and reducing factors that impact avoidable pharmacologic restraint use in the pediatric inpatient environment," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
American Psychiatric Association, May 4-8
The annual meeting of the American Psychiatric Association was held from May 4 to 8 in New York City, drawing participants from around the world, including clinicians...
Physicians With Disabilities May Experience Depersonalization
MONDAY, May 13, 2024 -- Physicians with disabilities (PWDs) are significantly more likely to experience depersonalization but not emotional exhaustion when compared with their...
Virtual Reality Therapy Can Augment Depression Treatment
MONDAY, May 13, 2024 -- Extended reality-enhanced behavioral activation (XR-BA) may be a feasible, noninferior, and acceptable enhancement to traditional BA for major depressive...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.